ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000879.1|Toyocamycin/sangivamycin_1 # 2 # 217 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.755	BGC0000879.1|Toyocamycin/sangivamycin_1 	2	217	-	Loose	1900	25.0238	MuxC	50.0	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCATCGCATCAGCCGGATGGACTGTCACGGCGGGTCTGTGCCCGGACGGCCGGCGCCCGCCGCGGTGCTGCCCCCGCCCCTGCGCGCGTGGCTCGGGCTGCTCGCGGCCCTCGCCACGCTGCCGGTCGTCGTGCTCGGTGTGCTGTACGCCGGCCACAGTGAGCCCGGCACGGCGGACGGGTGGTTCATCGACCCCATCGGCGGACAGTGTGCG	MHRISRMDCHGGSVPGRPAPAAVLPPPLRAWLGLLAALATLPVVVLGVLYAGHSEPGTADGWFIDPIGGQCA	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	6.95	gnl|BL_ORD_ID|2431|hsp_num:0	2720		
BGC0000879.1|Toyocamycin/sangivamycin_2 # 469 # 759 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000879.1|Toyocamycin/sangivamycin_2 	469	759	+	Loose	500	24.2534	Vibrio cholerae varG	27.91	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 Vibrio cholerae varG beta-lactamase	ATGACTGCATTTGACGACGGGGAGCATCACGGACGGTACGGAAGGCGCGAAGCCGATGTCCGTGAAGCCGTGTCGGTGACCGCCTTCACCGCGGCGGAGTTCGGCCGCGACGGGCACGACGGGCCGTTCCGGAAGCCCGTCGGGGACGGTACCCACGCGACCCTCACGGCACCGGCGCGGGCCCGTCCGCTGGTCGGGCCCGCCGTCGCGGACCGCTCCGTCCTCCGCGGCAACTGCCCCGGGCACGGACCGGAAGGGTCCGTTTCGTCCTCGTATCCCTCACCTGTGTGA	MTAFDDGEHHGRYGRREADVREAVSVTAFTAAEFGRDGHDGPFRKPVGDGTHATLTAPARARPLVGPAVADRSVLRGNCPGHGPEGSVSSSYPSPV	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	24.62	gnl|BL_ORD_ID|2495|hsp_num:0	2842		
BGC0000879.1|Toyocamycin/sangivamycin_3 # 1168 # 4053 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.746	BGC0000879.1|Toyocamycin/sangivamycin_3 	1168	4053	+	Loose	470	36.5798	sdiA	27.03	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTGTGGCAACGCCGACAGCGGAAGACACGTACCGCGCGAAGGACTCCGCGGTGCTCGCCCCTCGTCCGGAAATGCGGGTGTTACGCCAGGCACTGGCCGACAGCGGCGCCGGACGGGGCGGTCACTGGGTCGTGTACGGAGAAACCGGCGCGGGAAAGACCTCCGTTCTGCGCGCCCTTCGCGAAGAGGCCCGCGTGCTCGGCCACGCGGCCGTGGAACTGAAGTGCACGCCGATGGAGGGGTGCGTACCGTTCGCCACCGCGCGCAAGCTCGTCGCGCTGTTCGGCGCGTCACTCCCGGCGAGAGGTCCCGCCGCGGAAGCCCTGCGCCGGGCCGGCAGAGCGCTTTCGGGCCGTAACGGCTCGGCCGCGGGCCGGGGCTCGGGGCTGGGCGTGGTGCTCACCGGGCTCCAGGAGGCGGCCCAGGCCCTCACCGCGGCGGCCCCGCTGCTCATCACGGTCGACGACATCGGCTCGGCCGACGCCGCCTCGCTGGACTGCTTCTCCTACCTGCTGAACCAGTGCGAGGGAGTGCACCGCCTCCTGATCGTCGCGACGCTGGCCGACGGGGAACCGGTGCAGGCGCCGGCCGCGCTGGAGGGGCTGCGGCTCGGCGCCCGGGGACGTATCGACCTCGGCGGTCTCGACCTGCCGGGCACGGCCGAACTGGTGGCAGCCGTGACCGGCCGGCCGTGTGACGAGGGCCTCGCGGCGGCCTGCCGCACGGCGACGGCGGGCAACCCGCTGTTCCTGCGGGCCCTCGCGCGGTGCCTGCCGGCCCGGCGGCCCGTCCCCGCGCACGAGATCGCCGGGCTGGGGCCGCGAGCCGTCGCCGACCACGTACTGGCCCGGCTCGCGCGGATCTCGGAGCCGGCGTCGGCCATGGCCCGTACGGTCGCCGTACTCGGTGACGACACCGATCCGGCGATGGTCGCGGAGCTGGCGAACCTGGACTGCTCGACGGGCCTGGAGGCGGCGGACGTCCTGGTGCGCACGCGGCTGTTCCACGACGGGGGACAGATGTCGTTCCGCCATCCCGTCGTGGCGGCGGCGCTCCGCGAACAGACCTCCATCGTCGTCAAGAACACCCTGCACATGCAGGCCGCCGAGCATCTGCTCAGCCGTGACGCCCCGGCCGAGCAGGTGGCCGGGCACCTGATGGCGACCACCCTTCCCCTCACGTCCTCCTGGATGGTGGACGCGCTGCGGTCGGCGGCGCGGTCCGCCCTGGTACGGGAGGAAACGGGCACGGCAGTGGGGTACCTGCAACGGGCCGTGCAGGACGCGCGGGGCGTGGACTGGCGGCGGGCGGTCGCGCAGCTCGCGGACGCACAGCTGCTCACCGACCCCTCCGCCGCCATCGGCCGGCTCGCGGAGCTGGCCCGCCAGGGCGTGACCGCCGAAGAGCACCCGCAGCTCCTGGCCCGGCTCGCGGACGCGTCGTTCTTCTTCGCCACCCGCCCCCGGATACGGCACCAGCTGGACGAGGCGGTCGAGGCGGTCGCCGTCTCGCAGCCGCACTACACCGCCGACACACAGCTGTACCGGGCCCTGCACGCGCTGTCCGAGCTGCCCACCAAGGAAGCGTGCGAACTCGGGGACCGCTACCTCGCGTCCGAGCCCCGGGAAGGTGTGCTGCGCAGCGCGGCCGGGGCCCTGAGCGCCGTGAGCGCCTATGCGGCGGGCCGGGGCAGAAAGGCCGCGGTGGACCGGGTGAAGGAGGCGCTACGCGACCCCGACCTGTACGAACTCCCCAACACCGCGCCCCTGTGCGCCGGCACCGCGCTGCTGGCGCACGAGGGCGACCTCGACCTGGCCTCGGAGTACGCCCGGCACGGCATCGCCGTCGCGCGGCGGGAAGGGCGGCAGCTCCAGGTCGCCGCGCTCCTGCCGACCCTGGCGAAGATCGCCCAGGTACGCGGGGACCTGCGCGAGGCGGAGAACCTGCTGCGCACCTGCCTGAAGACCTTCGCGCGGTACGGGGTGTGGCGGGCCAACCCGGCCGCCCTCTGGGCCGGTTCCGTACTGGTCGGCGTCCTGGTCGACCTGGGCGAGCCGGCCGCCGCCCGCACGGTGCTCAGCGAGAGCGGCTGCCACGGCGACCTGCCGGCGATGTGGTCGACGCAGGCGATGCTGGAGCAGCGGGCCCGGGTGCGCATGGCGGCCGGAGAACTCACCGACGCGCTGGAGGACCTGCGCGAGTGCGGCCGGCGCTCGGCGGCGCTGGGCCTGAACAGCGTCGAGTTCGGGGGCTGGCGCCGGCTGGCCGCCGAGGTGCTGCACCAGTTGGGGCGGCCCGACGAGGCGAGGCGGCTGGCGGAGGAGGAGCTGGCGGCCGTACGGGGCCAGGCCACCGACCGTACCCAGGGAGCCGCCCTGCGCACGGCAGCACGGGTCATCGGCGGCGACGCGGGCCTGGGGCCGGCGCGGGAGGCGGTGCGGATCCTGGCGGGCACCCCCGACGTGCTGGAGCTGGCCCGCGCCCAGCTGACGCTGGGCACCCTGCTCGGGGGCACCGGCGACCGGACCGCCGCCCAGGGAACCCTGGCGCAGGCGCACGCGCTCGCGAGCCGCTGCGGTGCGGCGCCGGTCGAGGAACAGGCCCGCGAGCAGCTGCACGCCCTGGGGCGGCAGCACGGCGGCCGGGCCGTGACCGGGCTGCTGTCCCTGACCAGACGGGAGCGGCAGGTACTGGCCGATGCCGTACGCGGCCGCAGCAACGGCGCGATCGCCGACGCCCTCTTCATCACCCGGCGCACCGTGGAGATTCATCTGACCAGTGCCTACCGCAAACTCGGCATCCAAGGGCGCAAGGAGTTCGCGCAGCTCTACAACCGGCAGGAATTGTGGGCCCTGTTGACGGAGGAAACGGCCGGCAGGTGA	MSVATPTAEDTYRAKDSAVLAPRPEMRVLRQALADSGAGRGGHWVVYGETGAGKTSVLRALREEARVLGHAAVELKCTPMEGCVPFATARKLVALFGASLPARGPAAEALRRAGRALSGRNGSAAGRGSGLGVVLTGLQEAAQALTAAAPLLITVDDIGSADAASLDCFSYLLNQCEGVHRLLIVATLADGEPVQAPAALEGLRLGARGRIDLGGLDLPGTAELVAAVTGRPCDEGLAAACRTATAGNPLFLRALARCLPARRPVPAHEIAGLGPRAVADHVLARLARISEPASAMARTVAVLGDDTDPAMVAELANLDCSTGLEAADVLVRTRLFHDGGQMSFRHPVVAAALREQTSIVVKNTLHMQAAEHLLSRDAPAEQVAGHLMATTLPLTSSWMVDALRSAARSALVREETGTAVGYLQRAVQDARGVDWRRAVAQLADAQLLTDPSAAIGRLAELARQGVTAEEHPQLLARLADASFFFATRPRIRHQLDEAVEAVAVSQPHYTADTQLYRALHALSELPTKEACELGDRYLASEPREGVLRSAAGALSAVSAYAAGRGRKAAVDRVKEALRDPDLYELPNTAPLCAGTALLAHEGDLDLASEYARHGIAVARREGRQLQVAALLPTLAKIAQVRGDLREAENLLRTCLKTFARYGVWRANPAALWAGSVLVGVLVDLGEPAAARTVLSESGCHGDLPAMWSTQAMLEQRARVRMAAGELTDALEDLRECGRRSAALGLNSVEFGGWRRLAAEVLHQLGRPDEARRLAEEELAAVRGQATDRTQGAALRTAARVIGGDAGLGPAREAVRILAGTPDVLELARAQLTLGTLLGGTGDRTAAQGTLAQAHALASRCGAAPVEEQAREQLHALGRQHGGRAVTGLLSLTRRERQVLADAVRGRSNGAIADALFITRRTVEIHLTSAYRKLGIQGRKEFAQLYNRQELWALLTEETAGR	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	400.42	gnl|BL_ORD_ID|212|hsp_num:0	228		
BGC0000879.1|Toyocamycin/sangivamycin_4 # 4343 # 4708 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.661	BGC0000879.1|Toyocamycin/sangivamycin_4 	4343	4708	+	Loose	1700	24.6386	LpeB	27.78	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGGATTCCGTATCAGCAAAGAGTTCCACTTCTCCGCGAGCCACCGTCTGGACCACCTCGACGAAGGCCATCCCTGTTCCCGTATGCACGGGCACAACTACGTCGTCGAACTCGAACTGTCCGCCGGCGACGACGCCCTGACCAAGGCCGGCTTCGTCCGTGACTACGGGGAGCTCGCGGCCTTCAAGCAGTGGCTCGACGCCGAACTCGACCACCGGCACCTCAACGACGTGGTCGACGGCCTGAACCCGTCCGCCGAGAACCTGGCGCGGTGGATCCACGAGCGGTGGCGCACCGGCTTCCCGGAGCTGACCGCGGTCCGGGTCTCCGAGACCGACAAGACGTGGGCGGAGTACCGGGCATGA	MGFRISKEFHFSASHRLDHLDEGHPCSRMHGHNYVVELELSAGDDALTKAGFVRDYGELAAFKQWLDAELDHRHLNDVVDGLNPSAENLARWIHERWRTGFPELTAVRVSETDKTWAEYRA	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	11.93	gnl|BL_ORD_ID|2454|hsp_num:0	2759		
BGC0000879.1|Toyocamycin/sangivamycin_5 # 4705 # 4803 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.737	BGC0000879.1|Toyocamycin/sangivamycin_5 	4705	4803	+	Loose	450	20.4014	RanB	63.64	3005090	protein homolog model	n/a	n/a		antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCACGCGGCCCGCGGAGGCCGGGCGGGAGCGGGAAGGGGGTGGCGCCGCGGTGGGACCGAAGCTCGTGGTGAACGAGATCTTCGGCCCCACCTAG	MTTRPAEAGREREGGGAAVGPKLVVNEIFGPT	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	12.65	gnl|BL_ORD_ID|2868|hsp_num:0	3824		
BGC0000879.1|Toyocamycin/sangivamycin_6 # 4967 # 5479 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.704	BGC0000879.1|Toyocamycin/sangivamycin_6 	4967	5479	+	Loose	540	27.335	OXA-441	23.91	3003597	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCCTGGCGGGAGGTGCTGGAACGGCTGCTGGCCTACGAGGTCGACCTCATCGTCATCTCGGGCGGCGAACCGCTCAACCAGCAGCGCCGCCTGCTGCCCCTGGTGCGCGCGCTCCGCGACCACGGACGTGACGTGGAGATCGAGACCAACGGCACGGTCGCGCCGGACGCCGGCCTGGTGACCGGCGGCGTGCGGTTCAACGTCTCCCCCAAGCTGTCCCACTCCGGCGACCCCGAGAGCCGGCGGATCGTGCCCGAGGCGCTGCGGGCGCTGGCCGCGGTCCCCGGCACCGCCTTCAAATTCGTCTGCCGCGACGAGGAGGACCTGGAAGAGGTCGCCTCCGTCGTGGACCGCTGCGGCACCCGGCCGGTCTGGATCATGCCCGAAGGCCAGACGTCCGAAGCCACCCACCGACATCTCGCACGGCTCGGCGATCACGTCGTAGCACGCGGATGGAACCTCACCACACGCCTTCACGTGGCCGTGTGGGGCGACAGGAGAGCCATATGA	MPWREVLERLLAYEVDLIVISGGEPLNQQRRLLPLVRALRDHGRDVEIETNGTVAPDAGLVTGGVRFNVSPKLSHSGDPESRRIVPEALRALAAVPGTAFKFVCRDEEDLEEVASVVDRCGTRPVWIMPEGQTSEATHRHLARLGDHVVARGWNLTTRLHVAVWGDRRAI	MNIKALLLITSAIFISACSPYIVSANPNHSASKSDENAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTAVFKWDGQKRLFPEWEKNMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	62.04	gnl|BL_ORD_ID|2229|hsp_num:0	3511		
BGC0000879.1|Toyocamycin/sangivamycin_7 # 5476 # 6078 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0000879.1|Toyocamycin/sangivamycin_7 	5476	6078	+	Loose	1900	25.409	acrD	35.0	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGACGAGCGCCGAAACCCGCACGCTGGAGCTGCCGCGCGAGCACGCGGAGCCGGGCACCGACCCCCTGGAGACGCTGGCACGGCAGCTCCTCACCGAGATCGGTGAGGACCCGGACCGCTCCGGCCTGCGGGACACGCCGGCCCGCTTCGCGCGGTGGTGGAGGGAGTTCACCCAGTACGACCCCGGCCAGGTCGAGACCGTCTTCCCGCTGCACACCGTCGGGCAGCTGGTCACGGTCTCCGACATCCATGTGTGGTCGCTGTGCGAGCACCACCTGCTCCCGTTCTCGTGCACGCTCACGATCGCCTACCGGCCGGCGTCCCACGTGCTCGGGCTCTCGAAGTTCGCCCGTATCGCCCACCGCCACGCGCACCGGCTGCAGATCCAGGAGCGCCTCGTGCACGACATCGCTTCCGAGATCACGGCGGTGACCGGGTCGCCCGACGTGGCCGTGATCGGCAAGGGCGAGCACCTGTGCATGAGCATGCGGGGCATCCGCACGCCGGCGGTGATGACCTCGTCGGCGTTCACCGGGATCTTCGAGGACTTCGGGCCGGCGCGCGACGAGGTCGTGAGCGCGGCCGGCGGACCCCGCTGA	MTTSAETRTLELPREHAEPGTDPLETLARQLLTEIGEDPDRSGLRDTPARFARWWREFTQYDPGQVETVFPLHTVGQLVTVSDIHVWSLCEHHLLPFSCTLTIAYRPASHVLGLSKFARIAHRHAHRLQIQERLVHDIASEITAVTGSPDVAVIGKGEHLCMSMRGIRTPAVMTSSAFTGIFEDFGPARDEVVSAAGGPR	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	19.29	gnl|BL_ORD_ID|1342|hsp_num:0	1427		
BGC0000879.1|Toyocamycin/sangivamycin_8 # 6165 # 7319 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.740	BGC0000879.1|Toyocamycin/sangivamycin_8 	6165	7319	+	Loose	1800	26.9498	mexY	42.42	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAACCGTTGCGTGAAATCCCCACCGGCCTCGGGCTCGACGACGTCCTGCTCGTCCCCCAGCGCACCTCGGTCACCAGCCGTTCGCACACCGACGTCAGTACCGAACTCGTCCCGGGCCTGCGGCTGTCCGTACCGATCCTGTCCGCCAACACCCCGTGGTGCACCGGCGCCCGGATGGCCGCCGCCATGGCGCTGGCGGGCGGGCTCGGGGTCATCCACCGGATGCAGACGGCGGAGGACCAGGCGGCCGAGGTGACCGCGGTGAAGAAGGAACATCCCAAGGAGGAGTCCGCCGCCCCGGGCGCCACGGTCGACGAGCGGGGCCGGCTCCGCGCGGCGGCCGCCGTCGGGGTGACGGACGATTACCTCGACCGGGCGGCCCTCCTCGTCGAGGCCGGGGCCGACGCCCTGGTCGTCGATGTCGCGCACGGCCACGCGGACTACGTCCTCAAGGCCGTGGAGCAGCTGAAGTCCCGCTGGCCCGGCGTGCCCCTCGTGGGCGGCAACGTCGCGACTCCCGCCGGCACCAGGGACCTGATCGACGCCGGGGCGGATGCCGTGAAGGTCGGCATCGGGCCCGGCGGCATCTGCACCACGCGGCTGGTGGCCGGCAGCGGCATGCCGCAGTTCACCGCCGTACTGGAGTGCGCGGAGGAGGCCGCGGGGCGCGGCGTGCCGGTCATCGCGGACGGTGGCATCAAGGAGCCGGGCGACGTCGCGAAGGTGCTGGCGGCCGGTGCCCGGACGGCGATGCTGGGCAGCGCGCTCGCCGGTGCCGAGGAGAGCGCCGCCCTTCTGGTGGAGCACGACGGGCGGCCGGCGAAGGTGAGCACCGGGTTCGTGACGTTCGGCATGCAGCTGACCCTCAAGCGGGCCCGCGGTGAGGCGGTGACCAAGGAGGAACTGGCGCAGTACACGCCCGAAGGCGTGGAGGCGACGTGGCCCTTCAGCGGGCCGGCCGCCGGCACGGTGAACCGTTTCGTCGGCGGGCTGCGCTCCGGGATGAGCTACTCGGGCGCGCACACCCTCGCCGAGTTCCGCGAGCGGGCCTGCTTCGTCCGCGTCACCCCCGCCGGCCTGGCCGAGAACCACCCGCACGCCCTCGGACGCGCCCAGCAGGTCCCGCTCGACTACGCGGCGGAGGCGGTGTGA	MKPLREIPTGLGLDDVLLVPQRTSVTSRSHTDVSTELVPGLRLSVPILSANTPWCTGARMAAAMALAGGLGVIHRMQTAEDQAAEVTAVKKEHPKEESAAPGATVDERGRLRAAAAVGVTDDYLDRAALLVEAGADALVVDVAHGHADYVLKAVEQLKSRWPGVPLVGGNVATPAGTRDLIDAGADAVKVGIGPGGICTTRLVAGSGMPQFTAVLECAEEAAGRGVPVIADGGIKEPGDVAKVLAAGARTAMLGSALAGAEESAALLVEHDGRPAKVSTGFVTFGMQLTLKRARGEAVTKEELAQYTPEGVEATWPFSGPAAGTVNRFVGGLRSGMSYSGAHTLAEFRERACFVRVTPAGLAENHPHALGRAQQVPLDYAAEAV	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	36.71	gnl|BL_ORD_ID|1687|hsp_num:0	1786		
BGC0000879.1|Toyocamycin/sangivamycin_9 # 7316 # 8671 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.726	BGC0000879.1|Toyocamycin/sangivamycin_9 	7316	8671	+	Loose	500	25.409	OXA-250	32.73	3001675	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACGACCCCGATCGACACCGGCCGGTACGGCAGTCCGCGGATGCGCGCGCTGTTCACCGACCGGGCGCGCTACGAGGCGTTCGTACGGGTGGAGGGCGCGCTGGCCACGGCGCAGGGGCGGTACGGCGTCATTCCGCGGGAGGCGGCCGAAGCCATCGCCGAGCAGGCCCGCACCCACCGCTGCTCCCTGGAGCGCGTCGCCGCGCTCGAAGAGACGAGCCGCCACGAGCTGTTCGCCGCCGTACAGGAATTCGCCGAGTCCTGCGGCGCCCACGGCGCGTGGGTGCACTACGGGGCGACCAGCAGCGACATCCTGGACACCGCGCTCGCGCTCCAGCTCACCGAGGCCATCGCGCTGCTGGAGGAGGACCTGCGGGACCTCCTCACCGCGCTGCTGGCACGGATCGACGCGGTCGGTGACCACGTGATGATCGGCCGTACCCACGGCCAGCAGGCCCAGCCGGTGACGCTCGGATTCAAGCTGGCCATCGTGCTGGACCGGTTCGTGCGCTGCCTGGAACGGCTGGCCCAGGCCAAAGAGCGGGTCGTCATGGGCAAGATCGCGGGGGCGGTGGGGTCGCTCGCCGGGATCGGCGCGCACGGCCCCGAGGTGCAGCGGGAGACGCTGCGGGAGCTGGGCCTCCCGGAACCGGCCGTCTGCGCCCAGGCAGTGGCCCGGGACCGGATCGCCGAGTTCTTCTGCTGGGCGGGGCTGACGGCCGCCTGCCTGGAGGACCTGGCGACCGAGGTACGCAACCTGCAGCGTACGGAGATCGGCGAGGTCGCCGAACCGTTCGCCGAGGGCGGCCAGATCGGCAGCTCCGCCATGCCGCACAAGCGCAACCCCGTACAGAGTGAGCGCATCTGCAGCCTGGCGCGGCTGGTGCGCTCGCTCGTCGGGCCCGCGCTGGAGAACGTGACGAGCTGGCACGAGCGGGACCTGGCCAACTCCGCCAACGAACGGTTCACCCTGCCCGAGGCGTGCGTCCTGCTGGACGAGATGCTGACCACCGCCACGTACGTGATCGACGGCCTGCGGGTCTTTCCCGACCGGATGCGGCACAACCTGGAGCACTCGCACAACGAGCACCTCAGCGAGGCGGTCCTGCTGCTCCTCGTCCAGCGCGGCATGGACCGCCTGGCGGCGTACCGCCTGCTCCAGGAGGCCACCGGCCGGGCCACGGGCGAGGACGGCGACATGGTCGACGCCCTGCTGGCCCATCCGCGCCTCGCCGGCCGGCTCGACGCGGAAGAGGTCCGCCGGCTGGCTGCCGCGGGGGCCGACGTCGGGCACTGCCGGGACCTGACCGCCGCGGCCGTCAAGCGCGCCGAGCACATCGTCCAAGGAGGATGA	MTTPIDTGRYGSPRMRALFTDRARYEAFVRVEGALATAQGRYGVIPREAAEAIAEQARTHRCSLERVAALEETSRHELFAAVQEFAESCGAHGAWVHYGATSSDILDTALALQLTEAIALLEEDLRDLLTALLARIDAVGDHVMIGRTHGQQAQPVTLGFKLAIVLDRFVRCLERLAQAKERVVMGKIAGAVGSLAGIGAHGPEVQRETLRELGLPEPAVCAQAVARDRIAEFFCWAGLTAACLEDLATEVRNLQRTEIGEVAEPFAEGGQIGSSAMPHKRNPVQSERICSLARLVRSLVGPALENVTSWHERDLANSANERFTLPEACVLLDEMLTTATYVIDGLRVFPDRMRHNLEHSHNEHLSEAVLLLLVQRGMDRLAAYRLLQEATGRATGEDGDMVDALLAHPRLAGRLDAEEVRRLAAAGADVGHCRDLTAAAVKRAEHIVQGG	MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTLGDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	164.60	gnl|BL_ORD_ID|1889|hsp_num:0	2001		
BGC0000879.1|Toyocamycin/sangivamycin_10 # 8673 # 9728 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000879.1|Toyocamycin/sangivamycin_10 	8673	9728	+	Loose	1050	25.409	srmB	37.25	3002828	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGCCCTGCACCATCATCGTGGGCGGCCAGTGGGGTGACGAGGCCAAGGGCAAGATGGCCAGTTACCTGGCGCTCAAGGACGGCGTGGACCTCGCGGTGCGCGCCGGCCTCGGCCCGGGAGCCGGGCACACCATCGTGCACGGCGGACGGACGCACAAACTGCGCCAGGTCCCGAGCGCCGTGGTCAACGAGCGGACCCGGCTGCTGCTCGGCGCCGGTGTGCTCGTCAATCCGGAGGTACTGCTGCGGGAGATCGACGAGCTGGGGGTGGCCGACCGTATCGGCGTCGACTTCCGGGCGACCGTCATCGACCCCGGGCACGTCGAGGCCGAGCAGCGCGAACGCAATCTCACCGACACGGTCCGCAGCACCGGCAGCGGACACGGCCCCGCTCTCGCGGCACGCGCACTGCGCAACGCCCGCCGGGCGATGGACGTACCCGAACTGGCCCCCTACCTGGCGGACGTCGCCGTGGAGGTCAACGGCGCGGTGGACGCGGGCGCGCAGGTCCAGGTGGAGGGGACGAACGGGTTCGGCCTGTCGGTCCTGTACGGGACCTACCCGCACACGGTCGGCAAGGACAGCACGGCGAGCACGGCGGCCGCGGACGCCGGGCTGGGTCCGCTGGCCGTGGACGACGTGGTCCTGGTCTTCCGGGCCTACCCCACCCGCGTCGGGGCCGGCGCGTTCCCGACGGAGCTGCCCGAGCAGGAGGCGGAGCGCATCGGGGTCGAGTACGGCACGGTGACCGGACGGCGCCGGCGGATGGGCCGCTTCGACCTGGAGCAGGCCCGGGAGGCCGTACGGATCAACCGGCCCTCGCGCATCGCCGTCAGCTTCCTCGACTACCTGGCGCCGGAGGTCCGGGGGCAGCAGGAGGGCCCGCTGCCGCCCGGCGCGGCGGCCGGCCTCGTCGAAGAGATCGAACGCGAGCTGGGCGTACGGGTCGAGCTCCTCGGCACCGGACCGGGTACGGACGAGGTCATCGACCTGAGGCCCGCCCCCGCCGGCGCCGGCACCACAGCCCCCCTCCTCCGCACAAGGAGCACCGCATGA	MPCTIIVGGQWGDEAKGKMASYLALKDGVDLAVRAGLGPGAGHTIVHGGRTHKLRQVPSAVVNERTRLLLGAGVLVNPEVLLREIDELGVADRIGVDFRATVIDPGHVEAEQRERNLTDTVRSTGSGHGPALAARALRNARRAMDVPELAPYLADVAVEVNGAVDAGAQVQVEGTNGFGLSVLYGTYPHTVGKDSTASTAAADAGLGPLAVDDVVLVFRAYPTRVGAGAFPTELPEQEAERIGVEYGTVTGRRRRMGRFDLEQAREAVRINRPSRIAVSFLDYLAPEVRGQQEGPLPPGAAAGLVEEIERELGVRVELLGTGPGTDEVIDLRPAPAGAGTTAPLLRTRSTA	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	63.82	gnl|BL_ORD_ID|113|hsp_num:0	128		
BGC0000879.1|Toyocamycin/sangivamycin_11 # 9725 # 10255 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0000879.1|Toyocamycin/sangivamycin_11 	9725	10255	+	Loose	1100	26.9498	oleB	39.47	3003036	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGACCGCCGGACCGTCCCTGTGGAAGCGGCAGCGACTGCTCACCATGAGCTGGCAGACGCTCGGTACGCTGCTGACCGGCCTCGCCGAGGAGATCCGCGCCGCGGGCCCCCTCCCGGACACCGTCGTCGGTATCACCCGCGGCGGGCTCACCCCAGCCGTCGCCCTGGCGCACCGGCTGGACGTACCGGAGTTCCGGATCATGGGCATCCCGCGCAACTCCTCCAACAGCCGGTACAGCGAGCGCGGCGCGGCGGCACTGGAGTACGTCGTCCCGGACACCCCGCTGACGGGCAAGCGCGTCCTGGTCGTCGACGACATCATGGGCGACGGCGGCACGATGGAGACCGCGGTCGGCACCCTGCGTGCCCTGGACGCCGCGGAGATCCGCACCGCGGTCCTGGTGCGCAACCAGAACTGCGCCGGCCGGCCGGACCACCAGGGCGTCGAGGTCGACGACTGGACGGTCTTCCCGTGGGAGGCTCCGCCGGGCCCGGCGGAGCCGACCGTGCCGCTGGAGGCCGTGCGGTGA	MTAGPSLWKRQRLLTMSWQTLGTLLTGLAEEIRAAGPLPDTVVGITRGGLTPAVALAHRLDVPEFRIMGIPRNSSNSRYSERGAAALEYVVPDTPLTGKRVLVVDDIMGDGGTMETAVGTLRALDAAEIRTAVLVRNQNCAGRPDHQGVEVDDWTVFPWEAPPGPAEPTVPLEAVR	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	30.93	gnl|BL_ORD_ID|1304|hsp_num:0	1388		
BGC0000879.1|Toyocamycin/sangivamycin_12 # 10252 # 10977 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.752	BGC0000879.1|Toyocamycin/sangivamycin_12 	10252	10977	+	Loose	650	25.409	TriA	45.45	3003679	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGCTCCCCAGCGCGTCCGGGGCGCGGGTCTCCCGTGCCCCGGCGCGGCCCTCCCCCGCCACGGTCGTCTTCGACCGGGACGGCACCCTGCTGGACTTCTACGACATGTTCCACCGCTTCATCGTCGACCTGCACGACGCCCACGGGGTGGCGCCGCCCTCCCGGGAGGTGATCCTCGCGTACGAGTACTGGCAGACGATCACCAGCGGCCGGCTGCGCATCGGGGACACGGTCGTCCGCGACCGCGTGGACGAGGTGGTCCACCGCTACATGCCGCACGGCCGCCTCTTCCCCGGCACCGCGGAAGCGGTACGTGACCTGGGCGCGGCCGGCGTACGCGTGGTGCTGGTGAGCAGCTGGGTCGGCACCGCGGCGACCGGGGAACTCCTCGAACGGTACGGACTGCGCGGCGCGTTCGGCGCCGTCCTGACCCGCGACGACCTGGCGGCCGACGCGTCCCTGGCCACCGACGCGGAGTGCAAGACGGTCCTCGCCCGCCGGGCCCTGGCCGAGGTGGGACACCAGCCGGGCGACGCCCTGTACCTGGTCGGGGACACCTCGGCGGACATCGCTTCGGCCCGGATGCTCGGGGCCCGGGCCATCGGCGTGCGCACCGGAAACGGCAGCCGGCTGGCCGCGGTACCGGACGCCGGCCCGGACCGTCTCGTGGCCTGCGCCGCCGAGGCCGCGGCCGTCATCCTGCGGGAGGTGCGCGCGGGGTGA	MTLPSASGARVSRAPARPSPATVVFDRDGTLLDFYDMFHRFIVDLHDAHGVAPPSREVILAYEYWQTITSGRLRIGDTVVRDRVDEVVHRYMPHGRLFPGTAEAVRDLGAAGVRVVLVSSWVGTAATGELLERYGLRGAFGAVLTRDDLAADASLATDAECKTVLARRALAEVGHQPGDALYLVGDTSADIASARMLGARAIGVRTGNGSRLAAVPDAGPDRLVACAAEAAAVILREVRAG	MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP	62.92	gnl|BL_ORD_ID|2047|hsp_num:0	2192		
BGC0000879.1|Toyocamycin/sangivamycin_14 # 11673 # 11984 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000879.1|Toyocamycin/sangivamycin_14 	11673	11984	-	Loose	800	23.8682	adeG	32.61	3000778	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGTGAACGGCGGTTCTCCGTCGGGGATCCGGTCCGGGTGCGCCCGGCGGATCCGCCCCACCACACCCGGGTGCCCCGGTACGTACGGGGTCACCTCGGGCACGTCGTCACCGTACAACCGCCCTGCCCGCTTCCCGACGACGTGGCCCGGCGCCGGGATCCGTTCCGGGTCCTTCCCGTCTACACCGTGCGCTTCGCAGCGCGCGACCTGTGGGGCAGCGGGACACACCTCGTCCTGATCGACCTGTGGGAGTGCTACCTGGAACCGGCCGCCGAGACGGCCCGGGGCCTTGGAGGAGAAACATCATGA	MGERRFSVGDPVRVRPADPPHHTRVPRYVRGHLGHVVTVQPPCPLPDDVARRRDPFRVLPVYTVRFAARDLWGSGTHLVLIDLWECYLEPAAETARGLGGETS	MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQEYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGGGQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIVVNGLQRIRPGDPVTPHLVPMPNSQITASATPPQPQPTDKTSTPAKG	25.37	gnl|BL_ORD_ID|1155|hsp_num:0	1226		
BGC0000879.1|Toyocamycin/sangivamycin_15 # 11977 # 12252 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.659	BGC0000879.1|Toyocamycin/sangivamycin_15 	11977	12252	-	Loose	2130	23.0978	mtrD	40.62	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCACGGCTGAACGACATCGGCGGCACTTTCGGTTACGGCAGCATTCCGATGGACGGTGCGGAACCGCCGCACCCGTGGCGGCACGACTGGGAAGCACGGGTGTTCGCCGTGCTGATCGGCCTGGCGATGGCCGGTGTCTGGACCGCCTCGGAACTCCGCGACGCCGAGGAGCGCGTCCCGCCCAACGATTACCTCGCGGCCAGTTATTACGAGCGGGTGCTCATGGGCATGGAACTCCTCCTGGACGAGAAGGGGATTCCCTCCCGTGGGTGA	MARLNDIGGTFGYGSIPMDGAEPPHPWRHDWEARVFAVLIGLAMAGVWTASELRDAEERVPPNDYLAASYYERVLMGMELLLDEKGIPSRG	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	8.53	gnl|BL_ORD_ID|1829|hsp_num:0	1938		
BGC0000879.1|Toyocamycin/sangivamycin_16 # 12269 # 12985 # -1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0000879.1|Toyocamycin/sangivamycin_16 	12269	12985	-	Loose	500	24.6386	Vibrio cholerae varG	32.69	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 Vibrio cholerae varG beta-lactamase	TTGCCCGAATCGCCGGTCGAGGCCGACCCGTTCAGCGCCGTCGTCGTGCTGTCCGGCGGCATGGACTCCACGACGCTGCTCGCCCATTACGCCATGCTGCGCTACCGGCTCACCGCGGTGACGGTCGACTACGGTCAGCGCCACCGCCGGGAGATCGACGCGGCCCGGACGATCGCCGGGCACTACGGCGCGGAACACCATGTGGTGGACCTGAGCGGTATCGGGGTCCTGCTGGGCGGCTCCGCCCTGACCGACAGTGAGGTCGACGTCCCCTCAGGGCACTACGCCGAGGAGTCGATGCGGGCCACCGTCGTCCCCAACCGCAATGCCATCCTGGCCAATGTGGCGGTGGGCGCCGCGGTCGCGCGGCAGGCCGGCATCGTGGCTCTCGGAATGCACGCCGGTGACCATTTCGTCTATCCCGACTGCCGGCCGGCGTTCGTCGAGGCGCTGGACGGACTCGTCCGGGTCGCGAACGAGGGATTCGCCACGCCGCGGGTGGAAGCGCCATTCATCCACTGGAGCAAGACGGACATCGCGCGGTACGGGAGCCGGCTGGAAGCCCCGCTGGACAAGAGCTGGTCGTGCTACCGCGGCGGAGAACTCCACTGCGGTACCTGCGGTACGTGTTACGAACGCCGTGAGGCATTCCGTGACGCGGACGTGCCGGACCCGACGGAATACCTCGACGCCGCCACCGAATTCGCAGCGCCGTGA	MPESPVEADPFSAVVVLSGGMDSTTLLAHYAMLRYRLTAVTVDYGQRHRREIDAARTIAGHYGAEHHVVDLSGIGVLLGGSALTDSEVDVPSGHYAEESMRATVVPNRNAILANVAVGAAVARQAGIVALGMHAGDHFVYPDCRPAFVEALDGLVRVANEGFATPRVEAPFIHWSKTDIARYGSRLEAPLDKSWSCYRGGELHCGTCGTCYERREAFRDADVPDPTEYLDAATEFAAP	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	61.03	gnl|BL_ORD_ID|2495|hsp_num:0	2842		
BGC0000879.1|Toyocamycin/sangivamycin_17 # 13222 # 13749 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.723	BGC0000879.1|Toyocamycin/sangivamycin_17 	13222	13749	+	Loose	3000	24.2534	abcA	38.24	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACGACCGAGACCGGCCCCGTACAGCTGCTGACGATCGCGTTCGGCCCGGACGCGAAGTTCGAGGGGCGGATCATCGAGGAACTCGACGGCCTCACGGCCGCGGGCCAGATCCTCGTACTGGACCTGCTGGTCGTACAGAAGCAGCCCGGCGGTGACCTCGTCTCCGTCGGCTACCAGGCGGAAGGCATGGGCGACACGGTCAGCGCCCTGCTCGGACTGGGTCCGGGCGGCCTGCGGGGAGCGGAGGCGGCGTTCCCGTCCCTGGCACCGGGCCGCGCCTTCGGCCTCGGCGCGGACGACGTCCGGCAGCTCGCCGACTCCCTGGACCCGGGCACCACCGCGGCTTTCCTGCTGCTCGAACACCGCTGGGCGCGGAAGCTGCGGCACCTGGTCCGTGAGCAGGGAGGCGTGCCCGTGGCCGAGGGGTTCCTCACCGAAGAAGCGGTCGCCCCCATCGCCGCGGAGCTGCTCGCCGCCGCCACACGGCTGGACGAGGGGCCGACGGGAGAAAGGGGAGGGTCATGA	MTTETGPVQLLTIAFGPDAKFEGRIIEELDGLTAAGQILVLDLLVVQKQPGGDLVSVGYQAEGMGDTVSALLGLGPGGLRGAEAAFPSLAPGRAFGLGADDVRQLADSLDPGTTAAFLLLEHRWARKLRHLVREQGGVPVAEGFLTEEAVAPIAAELLAAATRLDEGPTGERGGS	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	12.05	gnl|BL_ORD_ID|2225|hsp_num:0	2416		
BGC0000879.1|Toyocamycin/sangivamycin_18 # 13746 # 14165 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000879.1|Toyocamycin/sangivamycin_18 	13746	14165	+	Loose	900	25.7942	otr(B)	34.15	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGGTTCCGTCACCCTCGCGTACGACTATCCGCTGCTCGGCGTCTTCTGGACCACGTTCTGGCTCTTCATGTGGGTGCTGTGGTTCTTCCTGCTCTTCCGCGTCATCGGCGACATCTTCCGTGACGACGGGATGAACGGCTGGGCCAAGACCGGCTGGATCCTCTTCGTCCTGGTGCTGCCCTTCCTCGGCGTCCTCGTCTACGTCCTCGCCCGGGGCCGCGGCATGGGCCGGCGCGAGGTGAACCGGGCGCAGGCCCAGCAGGAGGCGTTCGACGCGTACGTACGCCGGACCGCCACGGCGGGCACGCCCCGCGCCACCCCGGCCGACGAGCTGACGAAGCTCTCCCAGCTCAGGGAGCGCGGCGACATCTCGGAGGAGGAGTTCCAGCGGGCGAAGGGCGTGGTCCTGCACTGA	MSGSVTLAYDYPLLGVFWTTFWLFMWVLWFFLLFRVIGDIFRDDGMNGWAKTGWILFVLVLPFLGVLVYVLARGRGMGRREVNRAQAQQEAFDAYVRRTATAGTPRATPADELTKLSQLRERGDISEEEFQRAKGVVLH	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	24.69	gnl|BL_ORD_ID|910|hsp_num:0	870		
BGC0000879.1|Toyocamycin/sangivamycin_19 # 14224 # 14616 # 1 # ID=1_19;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.753	BGC0000879.1|Toyocamycin/sangivamycin_19 	14224	14616	+	Loose	700	25.409	Staphylococcus aureus norA	32.35	3004667	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGGGAGACATCGCAGGGTCACCGGCCGGCCCCTCTCCTCAGGAGGGCGGCGGGGCGGCGGCCGACGGCTCCGGTCCGTCGTCGCCGAAGCTCCGCCGTCGCCGGGGGCTGTGGTCCGTCACCCTGCCCGGGTGCTGGGGAGCGCTGCTGTTCGCCTGCCTCTCCTTCACCCCGTCGCTGCTCCCGCGCGGCGGCATCCTGCAGGGCCTGATCTGCGGTATCGACGCGGCCCTCGGGTACGCGGCCGGGGTGCTCGCCGCGCGGGTGTGGCGCGCGTTCGCCGACCGGGAGCCGCGGCCTCCGCGGCGCAGGTCCTGGACCGTCTTCTTCCTCGGCGCGGTCCTCCTCTTCGGCCTCTCCTTCGGCTTCGGGCAGTACTGGCAGTACCGG	MAGDIAGSPAGPSPQEGGGAAADGSGPSSPKLRRRRGLWSVTLPGCWGALLFACLSFTPSLLPRGGILQGLICGIDAALGYAAGVLAARVWRAFADREPRPPRRRSWTVFFLGAVLLFGLSFGFGQYWQYR	MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM	33.76	gnl|BL_ORD_ID|2263|hsp_num:0	3367		
